Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology
United States. Compilation of Patient Protection and Affordable Care Act: As Amended Through November 1, 2010 Including Patient Protection and Affordable Care Act Health-related Portions of the Health Care and Education Reconciliation Act of 2010. Washington: U.S. Government Printing Office, 2010.
- Kaiser Family Foundation; 2020. Available at:)https://www.kff.org/medicaid/issue-brief/status-of-state-medicaid-expansion-decisions-interactive-map/(Accessed November 20, 2021)Date: 2020 (
- Three-year impacts of the Affordable Care Act: improved medical care and health among low-income adults.Health Aff (Millwood). 2017; 36: 1119-1128
- Early coverage, access, utilization, and health effects associated with the Affordable Care Act Medicaid expansions: a quasi-experimental study.Ann Intern Med. 2016; 164: 795-803
- Trends in breast, colorectal, and cervical cancer incidence following the Affordable Care Act: implications for cancer screening.JAMA Oncol. 2018; 4: 128-129
- Associations of early Medicaid expansion with insurance status and stage at diagnosis among cancer patients receiving radiation therapy.Pract Radiat Oncol. 2020; 10: e207-e218
- Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act.Gynecol Oncol. 2017; 146: 457-464
- Trends in insurance status among patients diagnosed with cancer before and after implementation of the Affordable Care Act.J Oncol Pract. 2018; 14: e92-e102
- Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis.Am J Obstet Gynecol. 2021; 224: 195.e1-195.e17
- State Medicaid expansion status, insurance coverage and stage at diagnosis in head and neck cancer patients.Oral Oncol. 2020; 110: 104870
- The ACA and cancer screening and diagnosis.Cancer J. 2017; 23: 151-162
- Impact of the Affordable Care Act on colorectal cancer outcomes: a systematic review.Am J Prev Med. 2020; 58: 596-603
- Association of the Affordable Care act with ovarian cancer care.Obstet Gynecol. 2020; 135: 257-265
- Early impact of Medicaid expansion and quality of breast cancer care in Kentucky.J Am Coll Surg. 2018; 226: 498-504
- Effects of the Affordable Care Act on young women with gynecologic cancers.Obstet Gynecol. 2018; 131: 966-976
- Where you live matters: a National Cancer Database study of Medicaid expansion and endometrial cancer outcomes.Gynecol Oncol. 2020; 158: 407-414
- Association of Medicaid expansion and insurance status, cancer stage, treatment and mortality among patients with cervical cancer.Cancer Rep (Hoboken). 2021; 4: e1407
- Medicaid expansion and mortality among patients with breast, lung, and colorectal cancer.JAMA Netw Open. 2020; 3e2024366
- Using the National cancer database for outcomes research: a review.JAMA Oncol. 2017; 3: 1722-1728
- Surgeons ACo: National cancer database [Online].American College of Surgeons, Chicago, IL2021 (Available at: https://www.facs.org/quality-programs/cancer/ncdb)
- Measuring cause-and-effect relationships without randomized clinical trials: quasi-experimental methods for gynecologic oncology research.Gynecol Oncol. 2019; 152: 533-539
- Methods for evaluating changes in health care policy: the difference-in-differences approach.JAMA. 2014; 312: 2401-2402
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.J Clin Epidemiol. 1992; 45: 613-619
- Changes in mortality after Massachusetts health care reform: a quasi-experimental study.Ann Intern Med. 2014; 160: 585-593
- Mortality and access to care among adults after state Medicaid expansions.N Engl J Med. 2012; 367: 1025-1034
- Cancer statistics, 2020.CA Cancer J Clin. 2020; 70: 7-30
- Medicaid expansions and cervical cancer screening for low-income women.Health Serv Res. 2018; 53: 2870-2891
- Changes in breast and colorectal cancer screening after Medicaid expansion under the Affordable Care Act.Am J Prev Med. 2019; 57: 3-12
- Cervical and colorectal cancer screening prevalence before and after Affordable Care Act Medicaid expansion.Prev Med. 2019; 124: 91-97
- Effect of Medicaid expansion on colorectal cancer screening rates.Dis Colon Rectum. 2019; 62: 97-103
- Screening for ovarian cancer: US preventive services task force recommendation statement.JAMA. 2018; 319: 588-594
- The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer.Gynecol Oncol. 2020; 159: 309-316
- Insurance-mediated disparities in gynecologic oncology care.Obstet Gynecol. 2022; 139: 305-312
- Breast, cervical, and colorectal cancer screening: patterns among women with Medicaid and commercial insurance.Am J Prev Med. 2019; 57: 394-402
- To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study.Cancer Causes Control. 2022; 33: 403-415
- Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.Brachytherapy. 2019; 18: 29-37
- FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).MMWR Morb Mortal Wkly Rep. 2010; 59: 626-629
- Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.J Natl Cancer Inst. 2013; 105: 823-832
- Impact of socioeconomic status on survival in patients with ovarian cancer.Int J Gynecol Cancer. 2019; 29: 792-801
- Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.Gynecol Oncol. 2021; 160: 10-15
- Impact of quality of care on racial disparities in survival for endometrial cancer.Am J Obstet Gynecol. 2020; 223: 396.e1-396.e13
- Disparities in adherence to National Comprehensive Cancer Network treatment guidelines and survival for stage IB-IIA cervical cancer in California.Obstet Gynecol. 2018; 131: 899-908
- Prevalence of missing data in the National cancer database and association with overall survival.JAMA Netw Open. 2021; 4e211793
L.A.M. reports obtaining consulting fees from Bristol Myers Squibb, advisory board participation for GlaxoSmithKline, and stocks in Crisper, Invitae, and Bristol Myers Squibb. C.C.S. reports partial research funding from AstraZeneca and stock in Inform Genomics. The remaining authors report no conflict of interest.
This work was supported in part by the MD Anderson Cancer Center Support Grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH; NIH/NCI P30 CA016672 , CA217685 ) and the T32 training grant CA101642. L.A.M. is supported by a NIH-NCIK07-CA201013 grant. S.H.G. is supported by CPRIT RP160674 and Komen SAC150061.
Cite this article as: Huepenbecker SP, Fu S, Sun C, et al. Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis. Am J Obstet Gynecol 2022;227:482.e1-15.
The National Cancer Database (NCDB) is a joint project of the Commission on Cancer (CoC) of the American College of Surgeons and the American Cancer Society. The CoC's NCDB and the hospitals participating in the CoC's NCDB are the source of the de-identified data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.